ZANTE GREG (Chief Financial Officer) sold 3.4% of their position (6.18K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $216.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/28/2025ACC: 0001193125-25-254298
Officer· Chief Financial Officer
Since Jan 2021
+4.93K
Net shares
Net buyer
$216.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
11.12K acquired · 6.18K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+11.12K
Price / share
—
Trade value
—
% of position
6.6%
10/27/2025
168.66K→179.78K
Common Stock, par value $0.00001 per share
Direct
Shares
−6.18K
Price / share
$35.00
Trade value
$216.48K
% of position
3.4%
10/28/2025
179.78K→173.59K
Total
Net shares
+4.93K
Net value
-$216.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 10/27/2025 | A · Award | +11.12K | — | — | 6.6% | 168.66K | 179.78K |
| Common Stock, par value $0.00001 per share Direct | 10/28/2025 | S · Sale | −6.18K | $35.00 | $216.48K | 3.4% | 179.78K | 173.59K |
| Total | +4.93K | -$216.48K | ||||||
Derivative Transactions0
No derivative transactions reported